Benzinga - Sat, 08 May 2021 12:10:14 -0400
Benzinga - Thu, 06 May 2021 07:59:45 -0400
Benzinga - Thu, 06 May 2021 07:49:39 -0400
Benzinga - Thu, 06 May 2021 04:16:53 -0400
Benzinga - Wed, 05 May 2021 05:47:09 -0400
Benzinga - Sat, 01 May 2021 13:19:25 -0400
Benzinga - Thu, 29 Apr 2021 08:10:04 -0400
Benzinga - Thu, 29 Apr 2021 05:21:31 -0400
Benzinga - Wed, 28 Apr 2021 12:06:35 -0400
Benzinga - Wed, 28 Apr 2021 08:20:08 -0400
Benzinga - Wed, 28 Apr 2021 07:26:51 -0400
Benzinga - Wed, 28 Apr 2021 07:01:08 -0400
Benzinga - Wed, 28 Apr 2021 06:10:26 -0400
Benzinga - Wed, 28 Apr 2021 05:11:53 -0400
Benzinga - Tue, 27 Apr 2021 16:16:00 -0400
load more
Sector: Health Care.Industry: Biotechnology
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. Aldeyra's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.270-0.250 0.0200
REV0
Q4 2020Est.ActualSurprise
EPS-0.280-0.300 -0.0200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ALDXAldeyra Therapeutics3.57%593.3M

Aldeyra Therapeutics Company Questions & Answers

Q

How do I buy Aldeyra Therapeutics (ALDX) stock?

A

You can purchase shares of Aldeyra Therapeutics (NASDAQ: ALDX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Aldeyra Therapeutics's (ALDX) main competitors?

A

Other companies in Aldeyra Therapeutics’s space includes: Orchard Therapeutics (NASDAQ:ORTX), KalVista Pharmaceuticals (NASDAQ:KALV) and CytomX Therapeutics (NASDAQ:CTMX).

Q

What is the target price for Aldeyra Therapeutics?

A

The latest price target for Aldeyra Therapeutics (NASDAQ: ALDX) was reported by SVB Leerink on 2021-03-12. The analyst firm set a price target for 22.00 expecting ALDX to rise to within 12 months (a possible 76.28% upside). 7 analyst firms have reported ratings in the last year.

Q

How much is Aldeyra Therapeutics (ALDX) stock ?

A

The stock price for Aldeyra Therapeutics (NASDAQ: ALDX) is $12.48 last updated Fri May 07 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Aldeyra Therapeutics (ALDX) dividend?

A

There are no upcoming dividends for Aldeyra Therapeutics.

Q

When is Aldeyra Therapeutics (NASDAQ:ALDX) reporting earnings?

A
Aldeyra Therapeutics’s Q2 earnings are confirmed after-market from now on August 5, 2021.
Q

When is the upcoming split for ALDX?

A

There is no upcoming split for Aldeyra Therapeutics.